147 related articles for article (PubMed ID: 16570911)
1. Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues.
Pinchuk AN; Rampy MA; Longino MA; Skinner RW; Gross MD; Weichert JP; Counsell RE
J Med Chem; 2006 Apr; 49(7):2155-65. PubMed ID: 16570911
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution, metabolism, and excretion of radioiodinated phospholipid ether analogs in tumor-bearing rats.
Plotzke KP; Rampy MA; Meyer K; Ruyan M; Fisher SJ; Wahl RL; Skinner RW; Gross MD; Counsell RE
J Nucl Biol Med (1991); 1993 Dec; 37(4):264-72. PubMed ID: 8172971
[TBL] [Abstract][Full Text] [Related]
3. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
4. Selective localization of a radioiodinated phospholipid ether analog in human tumor xenografts.
Plotzke KP; Fisher SJ; Wahl RL; Olken NM; Skinner S; Gross MD; Counsell RE
J Nucl Med; 1993 May; 34(5):787-92. PubMed ID: 8386759
[TBL] [Abstract][Full Text] [Related]
5. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of radioiodinated phospholipid ether stereoisomers.
Rampy MA; Pinchuk AN; Weichert JP; Skinner RW; Fisher SJ; Wahl RL; Gross MD; Counsell RE
J Med Chem; 1995 Aug; 38(16):3156-62. PubMed ID: 7636878
[TBL] [Abstract][Full Text] [Related]
7. Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistry.
Schottelius M; Rau F; Reubi JC; Schwaiger M; Wester HJ
Bioconjug Chem; 2005; 16(2):429-37. PubMed ID: 15769098
[TBL] [Abstract][Full Text] [Related]
8. Antitumor alkyl ether lipid edelfosine: tissue distribution and pharmacokinetic behavior in healthy and tumor-bearing immunosuppressed mice.
Estella-Hermoso de Mendoza A; Campanero MA; de la Iglesia-Vicente J; Gajate C; Mollinedo F; Blanco-Prieto MJ
Clin Cancer Res; 2009 Feb; 15(3):858-64. PubMed ID: 19188156
[TBL] [Abstract][Full Text] [Related]
9. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues.
Miao Y; Whitener D; Feng W; Owen NK; Chen J; Quinn TP
Bioconjug Chem; 2003; 14(6):1177-84. PubMed ID: 14624632
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging.
Toyohara J; Kumata K; Fukushi K; Irie T; Suzuki K
J Nucl Med; 2006 Oct; 47(10):1717-22. PubMed ID: 17015909
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of radioiodinated phospholipid ether analogs.
Rampy MA; Chou TS; Pinchuk AN; Skinner RW; Gross MD; Fisher S; Wahl R; Counsell RE
Nucl Med Biol; 1995 May; 22(4):505-12. PubMed ID: 7550028
[TBL] [Abstract][Full Text] [Related]
14. Absence of preferential uptake of [125I]iododihydrorhodamine 123 by four human tumor xenografts.
Kinsey BM; Van den Abbeele AD; Adelstein SJ; Kassis AI
Cancer Res; 1989 Nov; 49(21):5986-8. PubMed ID: 2676153
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tissue distribution of cryptophycin 52 (C-52) epoxide and cryptophycin 55 (C-55) chlorohydrin in mice with subcutaneous tumors.
Boinpally RR; Polin L; Zhou SL; Jasti BR; Wiegand RA; White K; Kushner J; Horwitz JP; Corbett TH; Parchment RE
Cancer Chemother Pharmacol; 2003 Jul; 52(1):25-33. PubMed ID: 12739061
[TBL] [Abstract][Full Text] [Related]
16. Biological disposition and imaging of a radioiodinated alkylphosphocholine in two rodent models of breast cancer.
Rampy MA; Brown RS; Pinchuk AN; Weichert JP; Skinner RW; Fisher SJ; Wahl RL; Gross MD; Ethier SP; Counsell RE
J Nucl Med; 1996 Sep; 37(9):1540-5. PubMed ID: 8790215
[TBL] [Abstract][Full Text] [Related]
17. Impact of animal handling on the results of 18F-FDG PET studies in mice.
Fueger BJ; Czernin J; Hildebrandt I; Tran C; Halpern BS; Stout D; Phelps ME; Weber WA
J Nucl Med; 2006 Jun; 47(6):999-1006. PubMed ID: 16741310
[TBL] [Abstract][Full Text] [Related]
18. Potential tumor or organ-imaging agents. 30. Radioiodinated phospholipid ethers.
Meyer KL; Schwendner SW; Counsell RE
J Med Chem; 1989 Sep; 32(9):2142-7. PubMed ID: 2769685
[TBL] [Abstract][Full Text] [Related]
19. Methoxypoly(ethylene glycol)-conjugated carboxypeptidase A for solid tumor targeting: part II: pharmacokinetics and biodistribution in normal and tumor-bearing rodents.
Ton GN; Weichert JP; Longino MA; Fine JP; Kwon GS
J Control Release; 2005 May; 104(1):155-66. PubMed ID: 15866342
[TBL] [Abstract][Full Text] [Related]
20. In vivo studies on the availability and toxicity of antisense oligonucleotides in bladder cancer.
Blietz CE; Thode B; Hauses M; Pries R; Meyer AJ; Doehn C; Jocham D; Kausch I
In Vivo; 2009; 23(1):13-9. PubMed ID: 19368119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
